Life in the old dog yet: how biotech firms are looking to extend the lives of our pets
Briefly

As pet owners increasingly seek ways to extend their pets' lives, advancements in the science of aging and a variety of available longevity products have emerged. The rise of the pet supplement industry and new FDA-approaching interventions reflect a booming market. However, dog owners grapple with the ethical implications of their choices, questioning whether their investments serve their personal desires or truly benefit their pets. While typical dog lifespans in the UK average around 11 years, many are investing time and money in hopes of prolonging their beloved companions' lives.
With advancements in scientific understanding of aging mechanisms and various longevity products emerging, dog owners face the dilemma of whether to extend their pets' lifespans.
Despite the natural cycle of life and death, many pet owners are investing significantly in extending their pets' lives, raising questions about motivations behind such investments.
Read at www.theguardian.com
[
|
]